Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Hereditary pancreatic cancer

Written2000-12Ralph H. Hruban, Scott E. Kern
The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

(Note : for Links provided by Atlas : click)
 

Identity

Other namesFamilial pancreatic cancer
Atlas_Id 10068
Genes implicated inBRCA2  CDKN2A  MLH1  PALB2  PALLD  PHOX2B  PRSS1  STK11  TP53 
Inheritance it has been estimated that as many as 10% of pancreatic cancers have a hereditary basis; five genetic syndromes have been identified that are associated with the familial aggregation of pancreatic cancer; these include:
  • the second breast cancer syndrome (BRCA2),
  • the familial atypical multiple mole melanoma (FAMMM),
  • the Peutz-Jeghers Syndrome,
  • the hereditary pancreatitis and
  • the hereditary non-polyposis colorectal cancer (HNPCC) syndrome
  • most kindreds with familial pancreatic cancer, however, do not fall into one of these well-defined syndromes and these are referred to simply as "family pancreatic cancer."
    		•

    Clinics

    Note a generally accepted definition of familial pancreatic cancer is a kindred in which at least a pair of first-degree relatives (sibling-sibling or parent-child) have been diagnosed with pancreatic cancer; several large registries have been established to define the patterns of inheritance and genetic basis for the familial aggregation of pancreatic cancer in these kindreds; the National Pancreas Tumor Registry (NFPTR) is the largest such registry; over 260 familial pancreatic cancer kindreds have enrolled in this registry and studies of these kindreds has revealed that when followed prospectively, apparently healthy, first-degree relatives of patients with familial pancreatic cancer have an 18-fold increased risk of developing pancreatic cancer; when there are three or more family members with pancreatic cancer in a kindred, the first-degree relatives of the index patient with pancreatic cancer have a 56-fold increased risk of developing pancreatic cancer
    each of the five clinically recognized syndromes associated with the familial aggregation of pancreatic cancer has its own unique clinical findings

  • second breast cancer syndrome: the BRCA2 tumor suppressor gene is located on chromosome 13q and carriers of germline BRCA2 mutations have a significant lifetime risk of developing breast cancer (30-85%) at a young age; they are also at risk for bilateral breast cancer; BRCA2 is also associated with an increased risk of male breast cancer, ovarian cancer, prostate cancer and pancreatic cancer; the lifetime risk of pancreatic cancer in carriers of germline BRCA2 mutations is approximately 10%; germline BRCA2 mutations are particularly common amongst individuals of Ashkenazi Jewish heritage because of a founder effect

  • familial atypical multiple mole melanoma (FAMMM) syndrome has an autosomal dominant mode of transmission; most cases are caused by germline mutations in the p16 tumor suppressor gene on chromosome 9p; individuals affected with FAMMM develop multiple melanocytic nevi, some of which can be atypical; they also are at increased risk of developing melanoma and pancreatic cancer; the lifetime risk of pancreatic cancer in individuals with germline p16 mutations is about 20%

  • the Peutz-Jeghers Syndrome is inhertied in an autosomal dominant mode; it has recently been shown to be caused by germline mutaitons in the STK11/LKB1 gene on chromosome 19p; individuals with this syndrome typically develop multiple mucocutaneus melanin macules, harmartomatous gastrointestinal polyps and they have an increased risk of developing cancers of the gastrointestinal tract; it has been estimated that the lifetime risk of pancreatic cancer in patient with the Peutz-Jeghers Syndrome is approximately 30%

  • hereditary pancreatitis has an autosomal dominant mode of transmission; it is caused by germline mutations in the cationic trypsinogen gene (called PRSS1) on chromosome 7q35; affected individuals develop recurrent episodes of pancreatitis at a young age and they have an elevated lifetime risk of developing pancreatic cancers that approaches 40%

  • the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome is caused by germiline mutations in one of the DNA mismatch repair genes (such as hMLH1 on chromosome 3 p and hMSH2 on chromosome 2p); in addition to colorectal neoplasia, affected family members have an increased risk of developing pancreatic cancer; the pancreatic cancers that arise in patients with HNPCC often have a distinct histologic appearance referred to as "medullary" histology

  • the ataxia-telangectasia and familial adenomatous polyposis syndromes have also been associated with an increased risk of developing pancreatic cancer, however, these associations are not well-established
    • Treatment currently, there are no effective methods to screen individuals at-risk for early pancreatic cancer; several studies are underway to examine the effectiveness of endoscopic ultrasound (EUS) in the early detection of pancreatic cancer
    Prognosis prognosis will depend on the stage of the disease at diagnosis more than it does on hereditary sysceptibility

    Genes involved and Proteins

    Gene NameBRCA2 (breast cancer 2, early onset)
    Location 13q13.1
    DNA/RNA
    Description gene spanning more than 70kb of genomic DNA; the coding sequence comprises 27 exons (11 395 nucleotides)
    Protein
    Description the corresponding protein has 3 418 amino acid residues (384 kDa)
    Function the Brca2 protein binds to Rad51 and serves as an important co-factor in the Rad51 -dependent DNA repair of double strand breaks; the Brca2 protein may also have transcription activation potential
    Mutations
    Germinal more than 300 unique germ-line mutations have been reported; the 6174 delT mutation is particularly common in Jewish subjects
    Somatic acquired mutations in BRCA2 rare in pancreatic cancer

    Gene NameCDKN2A (cyclin dependent kinase 2a / p16)
    Alias MTS1, CDKN2A, p16 (INK4)
    Location 9p21.3
    DNA/RNA
    Description the coding sequence comprises 3 exons: this locus gives rise to 2 distinct transcripts from different promoters (p16 and p16(ARF))
    Protein
    Description the corresponding protein, called cyclin-dependent kinase inhibitor-2A, has 156 amino acid residues
    Function cyclin-dependent kinase inhibitor 2A binds to CDK4 and inhibits the ability of CDK4 to interact with cyclinA thereby inducing a G1 cell cycle arrest
    Mutations
    Germinal germline mutations are associated with the FAMMM Syndrome
    Somatic virtually all invasive pancreatic carcinomas show inactivation of the p16 gene; forty percent by homozygous deletion, 40% by an intragenic mutation coupled with loss of heterozygocity (LOH) and 15% by hypermethylation of the p16 promoter

    Gene NameSTK11 (serine/threonine kinase 11)
    Alias LKB1
    Location 19p13.3
    DNA/RNA
    Description gene Spanning 23kb of genomic DNA, the coding sequence comprises 9 exons (1446bp)
    Protein
    Description the corresponding protein has 433 amino acid residues
    Function serine throeonine protein kinase 11
    Mutations
    Germinal almost all germline mutations are predicted to disrupt the function of the kinase domain
    Somatic approximately 4% of sporadic pancreatic cancers have somatic inactivation of STK11

    Gene NamePRSS1 (protease, serine 1)
    Alias cationic trypsinogen, trypsin 1, trypsinogen 1
    Location 7q34
    DNA/RNA
    Description the coding sequence comprise 5 exons (800bp)
    Protein
    Description trypsin, which is active in the pacreas, in inactivated by cleavage; mutations which abrogate this cleavage site can result in autodigestion and pancreatitis
    Mutations
    Germinal the arg117-to-his mutation (R117H) is the most common mutation identified to date

    Gene NameMLH1 (human mutL homolog 1)
    Alias human homolog of MUTL
    Location 3p22.2
    DNA/RNA
    Description the coding sequence comprises 2484b
    Protein
    Description MLH1 forms a complex with other DNA mismatch repair gene; functions in DNA mismatch repairs
    Mutations
    Germinal one of at least 5 known human mismatch repair genes associated with the hereditary non-polyposis colorectal cancer syndrome: the neoplasms that develop in these patients typically show microsatellite instability

    Gene NameMSH2 (human mutS homolog 2)
    Alias human homolog of MULT S
    Location 2p21
    DNA/RNA
    Description the MSH2 locus covers approximately 73kb and contains 16 exons
    Protein
    Description MSH2 functions in DNA mismatch repair
    Mutations
    Germinal one of at least 5 known human mismatch repair genes associated with the hereditary non-polyposis colorectal cancer syndrome; the neoplasms that develop in these patients typically show microsatellite instability

    Bibliography

    Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells.
    Abbott DW, Freeman ML, Holt JT
    Journal of the National Cancer Institute. 1998 ; 90 (13) : 978-985.
    PMID 9665145
     
    A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK
    Cancer research. 1996 ; 56 (15) : 3409-3414.
    PMID 8758903
     
    Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.
    Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE
    Nature genetics. 1994 ; 8 (1) : 27-32.
    PMID 7726912
     
    Very high risk of cancer in familial Peutz-Jeghers syndrome.
    Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA
    Gastroenterology. 2000 ; 119 (6) : 1447-1453.
    PMID 11113065
     
    Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.
    Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, Sohn TA, Yeo CJ, Kern SE, Hruban RH
    The American journal of pathology. 1998 ; 152 (6) : 1501-1507.
    PMID 9626054
     
    Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE
    Cancer research. 1996 ; 56 (23) : 5360-5364.
    PMID 8968085
     
    Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
    Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark WH Jr
    The New England journal of medicine. 1995 ; 333 (15) : 970-974.
    PMID 7666916
     
    A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.
    Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, Järvinen H, Kristo P, Pelin K, Ridanp M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA
    Nature. 1998 ; 391 (6663) : 184-187.
    PMID 9428765
     
    Genetics of pancreatic cancer. From genes to families.
    Hruban RH, Petersen GM, Ha PK, Kern SE
    Surgical oncology clinics of North America. 1998 ; 7 (1) : 1-23.
    PMID 9443984
     
    Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance.
    JEGHERS H, McKUSICK VA, KATZ KH
    The New England journal of medicine. 1949 ; 241 (25) : page 993, illust; passim.
    PMID 15399020
     
    Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.
    Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M
    Nature genetics. 1998 ; 18 (1) : 38-43.
    PMID 9425897
     
    Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M, Gallinger S
    Cancer research. 2000 ; 60 (2) : 409-416.
    PMID 10667595
     
    Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.
    Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK Jr, Perrault J, Whitcomb DC
    Journal of the National Cancer Institute. 1997 ; 89 (6) : 442-446.
    PMID 9091646
     
    Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families.
    Lynch HT, Brand RE, Lynch JF, Fusaro RM, Smyrk TC, Goggins M, Kern SE
    Gastroenterology. 2000 ; 119 (6) : 1756-1760.
    PMID 11113097
     
    Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study.
    Lynch HT, Voorhees GJ, Lanspa SJ, McGreevy PS, Lynch JF
    British journal of cancer. 1985 ; 52 (2) : 271-273.
    PMID 4027169
     
    Docetaxel (Taxotere) in the neo-adjuvant setting in non-small-cell lung cancer.
    Mattson K
    Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 1999 ; 10 Suppl 5 : S69-S72.
    PMID 10582143
     
    Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.
    Ozçelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, Taylor BR, Narod SA, Darlington G, Andrulis IL, Gallinger S, Redston M
    Nature genetics. 1997 ; 16 (1) : 17-18.
    PMID 9140390
     
    Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
    Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, Shekher MC, Westerman AM, Entius MM, Goggins M, Yeo CJ, Kern SE
    The American journal of pathology. 1999 ; 154 (6) : 1835-1840.
    PMID 10362809
     
    Pancreatic cancer--more familial than you thought.
    Tascilar M, Tersmette AC, Offerhaus GJ, Hruban RH
    Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology. 1999 ; 19 (3-4) : 105-110.
    PMID 10866272
     
    Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
    Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH
    Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 ; 7 (3) : 738-744.
    PMID 11297271
     
    Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.
    Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD
    Nature genetics. 1996 ; 14 (2) : 141-145.
    PMID 8841182
     
    Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.
    Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M, Zahurak M, Johnson K, Tascilar M, Offerhaus GJ, Hruban RH, Kern SE
    The American journal of pathology. 2000 ; 156 (5) : 1641-1651.
    PMID 10793075
     

    Citation

    This paper should be referenced as such :
    Hruban, RH ; Kern, SE
    Hereditary pancreatic cancer
    Atlas Genet Cytogenet Oncol Haematol. 2001;5(1):72-75.
    Free journal version : [ pdf ]   [ DOI ]
    On line version : http://AtlasGeneticsOncology.org/Tumors/HeredPancrCanID10068.html

    External links

    OMIM260350
    OMIM606856
    OMIM613347
    OMIM613348
    OrphanetFamilial pancreatic carcinoma
    MeSHC535837  
    MedGenC535837  
    UMLSC2931038  
    ICD-10C25  
    Other databaseNational Familial Pancreas Tumor Registry
    Other databaseThe European Registry Of Hereditary Pancreatitis And Familial Pancreatic Cancer
    REVIEW articlesautomatic search in PubMed
    Last year articlesautomatic search in PubMed


    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Thu Feb 14 17:41:45 CET 2019

    Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    jlhuret@AtlasGeneticsOncology.org.